Blood conservation in surgery

被引:0
作者
Taleghani, BM [1 ]
Grossmann, R [1 ]
Reith, HB [1 ]
Wiebecke, D [1 ]
Thiede, A [1 ]
机构
[1] Univ Wurzburg, Chirurg Klin & Poliklin, Abt Transfus Med & Immunhamatol, D-97070 Wurzburg, Germany
来源
ZENTRALBLATT FUR CHIRURGIE | 2000年 / 125卷 / 02期
关键词
blood conservation; preoperative autologous blood donation; haemodilution; blood salvage; erythropoietin; side effects of allogeneic blood transfusion;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
The aim of all efforts to reduce the need of allogeneic blood transfusions is to avoid associated risks. There should particularly be a favourable effect according to the rate of transfusion-transmitted virus infections and immunological side-effects. The acceptance of an individually adjusted lowest haematocrit level and the minimisation of intra-operative blood loss by the application of optimal surgical techniques are among the most essential strategies to reduce or even avoid allogeneic blood transfusions. In addition the following interventions are generally accepted: Preoperative autologous blood donation, where appropriate supported by erythropoietin Preoperative haemodilution, where appropriate supported by erythropoietin Intra- and postoperative blood salvage Topical or systemic pharmacologic interventions to accelerate haemostasis Controlled hypotension Efficacy and indication of the different measures always depend on the individual circumstances of the specific patient. Therefore one should develop an individual approach for every case. In this context the most important subjects are an optimal coordination and if required an appropriate combination of the discussed methods. Algorithms which preoperatively allow approximate calculation of expected transfusion need may be a meaningful tool to facilitate blood conservation planning. However, at the same time one must consider that all strategies to reduce allogeneic transfusion needs are also associated with particular risks. Therefore one has to weigh carefully the pros and cons prior to their application, including the possible alternative of allogeneic transfusion in one's decision making process.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 122 条
[1]  
ANTANASSOFF PG, 1996, J CLIN ANESTH, V8, P446
[2]   FIBRIN GLUE [J].
ATRAH, HI .
BRITISH MEDICAL JOURNAL, 1994, 308 (6934) :933-934
[3]   BEDSIDE TRANSFUSION ERRORS - A PROSPECTIVE SURVEY BY THE BELGIUM SANGUIS GROUP [J].
BAELE, PL ;
DEBRUYERE, M ;
DENEYS, V ;
DUPONT, E ;
FLAMENT, J ;
LAMBERMONT, M ;
LATINNE, D ;
STEENSENS, L ;
VANCAMP, B ;
WATERLOOS, H .
VOX SANGUINIS, 1994, 66 (02) :117-121
[4]   A CONTROLLED TRIAL OF INTRAOPERATIVE AUTOLOGOUS TRANSFUSION IN CARDIOTHORACIC SURGERY MEASURING EFFECT ON TRANSFUSION REQUIREMENTS AND CLINICAL OUTCOME [J].
BELL, K ;
STOTT, K ;
SINCLAIR, CJ ;
WALKER, WS ;
GILLON, J .
TRANSFUSION MEDICINE, 1992, 2 (04) :295-300
[5]  
Bennett DR, 1997, AM J CLIN PATHOL, V107, pS23
[6]  
BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700
[7]   PROPOFOL FOR MAINTENANCE OF GENERAL-ANESTHESIA - A TECHNIQUE TO LIMIT BLOOD-LOSS DURING ENDOSCOPIC SINUS SURGERY [J].
BLACKWELL, KE ;
ROSS, DA ;
KAPUR, P ;
CALCATERRA, TC .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1993, 14 (04) :262-266
[8]   Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? [J].
Blajchman, MA .
TRANSFUSION, 1999, 39 (07) :665-670
[9]   HEPARIN COATING REDUCES BLOOD-CELL ADHESION TO ARTERIAL FILTERS DURING CORONARY-BYPASS - A CLINICAL-STUDY [J].
BOROWIEC, JW ;
BYLOCK, A ;
VANDERLINDEN, J ;
THELIN, S .
ANNALS OF THORACIC SURGERY, 1993, 55 (06) :1540-1545
[10]   Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation [J].
Boylan, JF ;
Klinck, JR ;
Sandler, AN ;
Arellano, R ;
Greig, PD ;
Nierenberg, H ;
Roger, SL ;
Glynn, MFX .
ANESTHESIOLOGY, 1996, 85 (05) :1043-1048